Nextera Attending BIO Europe Spring

Mar 4, 2020 | Meet us

https://informaconnect.com/bioeurope-spring/

CEO Geir Åge Løset and CBO Ole Henrik Brekke will attend the BIO Europe Spring Digital conference March 23rd – 25th. They will present NexCore and its applications for novel drug development to a panel of partners.

← Previous Next →

Recent

Nextera’s NextCore technology applied to develop a unique peptide activator of the tissue injury Factor-VII activating protease (FSAP) in human plasma
Nextera’s unique NextCore display technology combined with state-of-the-art computational guidance efficiently generates low picomolar affinity TCR-Like antibodies
Nextera AS announces strategic collaboration with Zelluna Immunotherapy AS on development of optimized TCRs for redirected cancer immunotherapy
NextCore-generated state-of-the-art TCR-Like antibodies in celiac disease published in Science Immunology.
Nextera appoints Dr. Bent Jakobsen to the Board of Directors

Sort by

Meet us
News
Publications

Nextera Attending BIO Europe Spring

Recent

Sort by

Nextera AS

Contact

Navigation

Recent news

Nextera’s NextCore technology applied to develop a unique peptide activator of the tissue injury Factor-VII activating protease (FSAP) in human plasma

Nextera’s unique NextCore display technology combined with state-of-the-art computational guidance efficiently generates low picomolar affinity TCR-Like antibodies